The smooth-to-rough colony morphology shift in Mycobacterium abscessus has been implicated in loss of glycopeptidolipid (GPL), increased pathogenicity, and clinical decline in cystic fibrosis (CF) patients. However, the evolutionary phenotypic and genetic changes remain obscure. Serial isolates from nine non-CF patients with persistent M. abscessus infection were characterized by colony morphology, lipid profile via thin-layer chromatography and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), sequencing of eight genes in the GPL locus, and expression level of fadD23, a key gene involved in the biosynthesis of complex lipids. All 50 isolates were typed as M. abscessus subspecies abscessus and were clonally related within each patient. Rough isolates, all lacking GPL, predominated at later disease stages, some showing variation within rough morphology. While most (77%) rough isolates harbored detrimental mutations in mps1 and mps2, 13% displayed previously unreported mutations in mmpL4a and mmpS4, the latter yielding a putative GPL precursor. Two isolates showed no deleterious mutations in any of the eight genes sequenced. Mixed populations harboring different GPL locus mutations were detected in 5 patients, demonstrating clonal diversification, which was likely overlooked by conventional acid-fast bacillus ( MABSC causes serious chronic pulmonary infections in those with underlying conditions such as bronchiectasis or cystic fibrosis (CF). In the United States and some other parts of the world, it is the second most frequent pulmonary nontuberculous mycobacterial (NTM) infection (28%), after Mycobacterium avium complex, and its prevalence is increasing (6, 7). MABSC causes significant mortality in the CF population. In Scandinavian countries, one-fourth of CF patients who have persistently positive MABSC sputum cultures have received lung transplantation or died (8).
O
rganisms within the so-called Mycobacterium abscessus complex (MABSC) belong to the rapidly growing mycobacteria. Increasing evidence supports the division of MABSC into three related subspecies: M. abscessus subspecies abscessus (here referred as M. abscessus), M. abscessus subspecies massiliense, and M. abscessus subspecies bolletii (1) (2) (3) (4) (5) .
MABSC causes serious chronic pulmonary infections in those with underlying conditions such as bronchiectasis or cystic fibrosis (CF). In the United States and some other parts of the world, it is the second most frequent pulmonary nontuberculous mycobacterial (NTM) infection (28%), after Mycobacterium avium complex, and its prevalence is increasing (6, 7) . MABSC causes significant mortality in the CF population. In Scandinavian countries, one-fourth of CF patients who have persistently positive MABSC sputum cultures have received lung transplantation or died (8) .
Glycopeptidolipid (GPL) is the most abundant glycolipid in the outer cell envelope of MABSC, and its synthesis and transport are controlled by the GPL locus (9) . A growing number of studies have linked the rough colony morphology in MABSC to loss of GPL, increased pathogenicity, and clinical decline in CF patients (10) (11) (12) (13) (14) (15) (16) . While most studies of persistent MABSC infection focused on CF patients, less is known about MABSC in the non-CF population regarding presence of mixed populations, clonal relatedness, and phenotypic and genotypic changes of strains collected over time.
We have very limited understanding of the evolutionary phenotypic and genetic changes occurring in MABSC during persistent human lung infection. We lack the fundamental knowledge needed to identify selective pressures associated with rough morphology and, once identified, how to reverse them. To address these questions, we collected serial clinical isolates of M. abscessus from non-CF patients with persistent pulmonary infection who were followed for 5 years or more and assessed strain relatedness and diversity, colony morphology, lipid profiles, mutations in GPL locus genes, and lipid metabolism.
MATERIALS AND METHODS
Mycobacterial isolates and culture. The clinical isolates were kept at Ϫ80°C in Tween-albumin broth (Remel, Lenexa, KS) at the Microbiology Service of the NIH Clinical Center. Each isolate was labeled with patient number, chronological isolate number, and colony morphology [e.g., the third isolate from patient 6 with rough morphology is 6-3(R)]. Prior to use, the isolates were cultured on Middlebrook 7H11 agar plates at 37°C for 3 to 5 days. For experiments requiring growth in liquid medium, colonies were inoculated into Middlebrook 7H9 broth supplemented with albumin, dextrose, and catalase (ADC) with 0.05% Tween 80. Microscopy. Pictures of colonies were taken after 72 to 96 h of incubation at 37°C on 7H11 agar plates using a light microscope (Nikon Eclipse 50i) equipped with a camera (Olympus DP70) at a magnification of ϫ100.
DNA extraction from mycobacterial isolates. DNA was extracted from each isolate by use of the Mo Bio Ultra Clean microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA) according to the manufacturer's instructions.
Sequencing of 8 GPL locus genes. Whole-genome sequencing (WGS) of mycobacteria was previously done on the 19 isolates from patients 1, 7, and 9. These isolates were 1-2(S) to 1-7(S), 7-1(S) to 7-4(R) and 7-6(S) to 7-8(R), 9-1(S) to 9-6(R) (see Table S1 in the supplemental material for NCBI accession numbers). Discrete gene sequences were obtained from the WGS data. The remaining 31 isolates were subjected to targeted sequencing of 8 genes in the GPL locus as described below.
Amplification of the genes of interest was performed using Platinum Taq Hi-Fidelity Supermix (Life Technologies, Carlsbad, CA) per the manufacturer's instructions. The primers were chosen based on the reference genome of M. abscessus ATCC 19977 T available in NCBI (see Table S2 in the supplemental material). The resulting PCR products were treated with ExoSAP-IT (Affymetrix, Santa Clara, CA) and sequenced using BigDye v3.1 Ready Reaction mix (Life Technologies). Reaction products were purified using DTR Performa spin plates (Edge BioSystems, Gaithersburg, MD) and run on a 3730XL DNA Analyzer (Life Technologies). Chromatograms were aligned and analyzed using Sequencher (Gene Codes, Ann Arbor, MI).
Multilocus genotyping of the clinical isolates.
Primers were chosen based on previously reported multilocus sequence typing (MLST) schemes (3, 5) (see Table S2 in the supplemental material). Following PCR amplification and sequencing, partial sequences of the 3 housekeeping genes hsp65, secA, and rpoB from each genome were concatenated. For the 19 isolates that underwent WGS previously, sequences were obtained from the WGS data. The concatenated sequences were aligned by the ClustalW algorithm and used for construction of a neighbor-joining phylogenetic tree by MEGA software.
Extraction of crude GPL from M. abscessus clinical isolates and TLC. Crude GPL was extracted as previously described (17) . Briefly, strains grown on the 7H11 agar plates were inoculated into 7H9 liquid medium supplemented with ADC. After growth for 72 to 96 h at 37°C with continuous shaking, optical densities at 600 nm (OD 600 ) were measured (DU-530 spectrophotometer; Beckman, Indianapolis, IN). Cultures were diluted with fresh 7H9 liquid medium to an OD 600 of 0.025 and grown to logarithmic growth phase (OD 600 , 0.6 to 0.9). After washing twice with phosphate-buffered saline (PBS), bacterial pellets were weighed to keep differences among serial isolates from a patient within 10% of each other. Pellets were resuspended in 2:1 chloroformmethanol (10 l per mg wet pellet) and left overnight for lipid extraction. Following centrifugation, 2 l of the supernatant containing extracted total unbound lipids was used for matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (see below). For further extraction of crude GPL, 0.9% NaCl at 20% of the volume of the supernatant was added. After vortexing and centrifugation, the organic layer containing GPL (bottom) was separated from the aqueous layer (top) and left for complete evaporation of the solvent. Crude GPL extract was then resuspended in 20 l of 2:1 chloroform-methanol, spotted on an analytical thin-layer chromatography (TLC) plate (Silica Gel 60; EMD Millipore, Germany), and run in 100:7 chloroform-methanol, followed by spraying with 0.1% orcinol in 40% H 2 SO 4 and charring at 140°C for visualization.
MALDI-TOF MS of lipid extracts. The total unbound lipid extracts from before the biphasic separation were subjected to MALDI-TOF MS. Two microliters of the lipid extract was dried on a steel MALDI-TOF MS sample target on a heat plate at 45°C. This was overlain with the matrix solution (1 l of saturated ␣-cyano-4-hydroxycinnamic acid [CHCA] in (18, 19) . We chose to do qPCR of the 16S rRNA gene because it is highly conserved and only a single copy exists in the M. abscessus genome. After harvesting liquid cultures at an OD 600 of 0.6 to 0.9, samples underwent water bath sonication (Aquawave 9374; Barnstead Lab-Line, Germany) with glass beads for 15 min to minimize clumping, followed by vigorous vortexing, and then 20 l from each sample was lysed at 100°C for 15 min in a thermocycler. Absolute quantification of the 16S rRNA gene with an Applied Biosystems 7500 real-time PCR system (Grand Island, NY) was performed using 2 l of the lysate along with 0.6 M each primer (see Table S2 in the supplemental material), 21 l of SYBR green PCR master mix (Applied Biosystems, Grand Island, NY), and 21 l of water (total reaction volume, 50 l). The initial holding stage was set to 95°C for 15 min, followed by 40 cycles of 1 min at 94°C and 1 min at 60°C. Fluorescence measurement was taken during the 60°C step in each cycle. Standard curves were generated using the purified PCR product from amplification of the 16S rRNA gene with the same primers and genomic DNA from a smooth M. abscessus clinical strain. The weight of the PCR product in 2 l and its base pair length obtained from the 2100 Bioanalyzer system (Agilent Technologies, Santa Clara, CA) were converted to the number of copies of the 16S rRNA gene using the following formula: number of copies ϭ (weight in ng ϫ 6.022 ϫ 10 23 )/(base pair length ϫ 10 9 ϫ 660), where the estimation for the weight of one base pair is 660 Da (QuantiTect SYBR; Qiagen [2002] ).
TLC separation of TAG and detection by MALDI-TOF MS.
A 250-l portion of each liquid culture sample normalized by copy numbers of the 16S rRNA gene (10 8 copies per ml) underwent the crude lipid extraction as described above, followed by TLC for separation of triacylglycerol (TAG). The solvent system used was hexane-diethyl ether-acetic acid at 70:30:1 (20) . After the run, the TLC plate was sprayed with 10% CuSO 4 in 10% phosphoric acid and charred at 110°C until the separated lipids were visualized (21) .
Two separate plates, both loaded with the crude lipid extract from 1-8(R), underwent the TLC runs for TAG as described above simultaneously in the same tank. One plate was sprayed and charred for visualization, while the other was left intact. The silica in the band corresponding to TAG on the intact plate, in comparison to the visualized counterpart, was scraped off and washed with 2:1 chloroform-methanol. After centrifugation, the supernatant was subjected to MALDI-TOF MS as described above.
RNA extraction from the mycobacteria and conversion to cDNA. Liquid culture samples normalized by copy numbers of the 16S rRNA gene (10 8 copies per ml) were subjected to RNA isolation (Qiagen, 2006). The concentration of the extracted total RNA in ng/l was measured with a NanoDrop ND-100 spectrophotometer (Thermo Scientific, Wilmington, DE). Twelve nanograms of the total RNA was converted to cDNA (SuperScript III quantitative reverse transcription-PCR [qRT-PCR]; Invitrogen, Grand Island, NY), following the manufacturer's instructions.
Measurement of cDNA copy numbers of fadD23. Absolute quantification with the Applied Biosystems 7500 real-time PCR system was performed using 4 l of the cDNA sample from the step described above, 0.6 M each primer targeting fadD23 (see Table S2 in the supplemental material), 20 l of SYBR green PCR master mix, and 20 l of water in a total reaction volume of 50 l. The initial holding stage was set to 95°C for 10 min, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. Fluorescence measurement was taken during the 60°C step in each cycle. Standard curves were generated as described above.
RESULTS

Patients.
All available serial isolates from the non-CF patients with persistent M. abscessus pulmonary infection who were followed at the NIH Clinical Center for 5 years or more were included in the study (9 patients, total of 50 isolates). The median follow-up time was 8 years, with a maximum of 12 years.
The majority of patients (8 out of 9) had pulmonary NTM disease with idiopathic bronchiectasis. One had disseminated infection due to interferon gamma autoantibodies (Table 1) . 
Phylogenetic analysis of the clinical isolates by MLST.
Chronic infection with MABSC could potentially result from persistence of the initial strain and/or from reinfection with other strains. In order to differentiate between these two scenarios, all serial isolates were typed by a molecular method. Close genetic relatedness among serial isolates by patient is shown by the phylogenetic analysis based on multilocus sequence typing (MLST) using concatenated hsp65, secA, and rpoB sequences supporting strain persistence (3) (Fig. 1) . Therefore, the changes observed among the serial isolates reflect adaptive processes of M. abscessus in response to chronic human lung infection.
Single-colony morphology. Smooth and rough colony morphotypes were assessed by microscopic inspection of isolates on 7H11 agar plates, ( Fig. 2; see Fig. S1 in the supplemental material). In 6 out of the 9 patients, the colony morphology of the serial isolates was initially smooth before becoming predominantly rough. Serial isolates from the other 3 patients showed rough colony morphology throughout.
GPL locus mutations in the rough clinical isolates. We analyzed 8 genes in the GPL locus, including the genes in which spontaneous insertions/deletions (indels) were previously identified in rough M. abscessus clinical strains (mps1 and mmpL4b) (22) as well as those which when experimentally rendered nonfunctional resulted in a switch from smooth to rough in M. abscessus or M. smegmatis (gap, mps2, mbtH, mmpL4b, and mmpS4) (17, (23) (24) (25) . fmt and mmpL4a were included because of their adjacency to the above genes (Fig. 3) . None of the 11 smooth isolates had a detrimental mutation in the 8 genes sequenced (in the entire GPL locus for those isolates with WGS data). Out of a total of 39 rough isolates, 35 (90%) had detrimental mutations, ranging from a single-base-pair indel to a 3.1-kbp deletion in mps1-mps2 or mmpS4-mmpL4a. None of the 35 isolates had more than one detrimental mutation in the 8 genes (in the entire GPL locus for the isolates with WGS data). We also observed different GPL locus mutations within individual patients' isolates (patients 1, 4, 5, 7, and 9). For the remaining 4 rough isolates, 1-3(R) and 5-4(R) carried nonsynonymous SNPs with unclear consequences in mps1 and mps2, respectively. Interestingly, no detrimental mutations in 5-3(R) or 5-5(R) were identified within the 8 genes sequenced (Table 2) .
Overall, the majority of the detrimental GPL locus mutations in the rough clinical isolates occurred in the mps1-mps2 segment (77% of the rough isolates). In 13% of the strains, changes were found in the mmpS4-mmpL4a segment. Mutations in mmpS4-mmpL4a have not been reported previously in spontaneously occurring rough strains of M. abscessus.
MALDI-TOF MS and TLC of the crude GPL extracts.
We performed MALDI-TOF MS on the crude unbound lipid extracts from all 50 clinical isolates ( Fig. 4 ; see Fig. S2 in the supplemental material). The isolates determined as smooth by microscopy had MALDI-TOF MS spectra that matched the previously published GPL spectrum of M. abscessus (9) . On the other hand, none of the 39 rough isolates showed spectra of GPL; 37 had no spectrum in   FIG 3 A segment of the GPL locus at the 5= end in the M. abscessus genome, as described by Ripoll et al. (9) . The genes in bold at the top are the 8 genes that underwent targeted sequencing in this study. We found a detrimental mutation in 4 of the 8 genes (mmpS4, mmpL4a, mps1, and mps2 [*]) in 35 of the 39 rough clinical isolates included in the study. Most of these mutations were present in either in mps1 or mps2, but the 3 rough isolates from patient 7 had detrimental mutations in mmpL4a, while the 2 rough isolates from patient 2 had them in mmpS4.
TABLE 2 GPL locus mutations identified in the rough isolates
Patient
GPL locus mutation(s) in the rough isolates Consequence Frameshift the molecular mass range of GPL. Only two rough isolates, 2-1(R) and 2-2(R), with frameshift mutations in mmpS4 had spectra in the GPL range, but their peaks had atomic mass values higher than those of GPL (Fig. 4) . TLC on the extracts from all 39 rough isolates did not show bands corresponding to GPL. Variation in rough morphology. Although the rough isolates were clearly distinguishable from the smooth isolates, there was significant variation in rough morphology. The rough colonies of serial isolates from patients 4, 5, and 6 ( Fig. 2; see Fig. S1 in the supplemental material) became denser and more irregularly shaped in the later-disease isolates. This variation in rough morphology was independent of GPL locus mutation. For example, all patient 6 serial isolates were devoid of GPL and had the same single-base-pair deletion in mps1 (5714delT), but they showed significant variation in rough morphology.
Accumulation of TAG in the later clinical isolates. The accumulation of triacylglycerol (TAG) and the downregulation of synthesis of complex lipids occur in M. tuberculosis in response to various stressors in the human lung, such as hypoxia and low pH, presumably enabling the use of host fatty acids and cholesterol for an energy source (26) (27) (28) (29) . To test if TAG accumulation occurs in M. abscessus during chronic human lung infection, we performed TLC to separate TAG, using the samples normalized by copy numbers of the 16S rRNA gene. The bands corresponding to TAG were darker on the TLC runs of the later-collected serial isolates ( Fig. 5; see Fig. S3 in the supplemental material), suggesting accumulation of TAG in M. abscessus during infection of human lung. MALDI-TOF MS on the silica scraped from the TAG bands showed peaks that matched the molecular masses of TAG (Fig. 5 ) and were consistent with those reported previously (30) .
Reduced expression of fadD23, which is involved in synthesis of complex lipids. fadD23, one of the M. abscessus genes in the GPL locus (9), encodes a fatty acyl-AMP ligase (FAAL) that activates long-chain fatty acids as acyl-adenylates, which are then further modified and extended for production of complex lipids such as GPL (31) . fad23 is orthologous to fadD26 in M. tuberculosis, with 52% amino acid identity and sharing of conserved domains specific to FAAL family proteins. fadD26 is well described as playing a crucial role in the biosynthesis of complex lipids that populate the outer cell envelope in M. tuberculosis (28, 32) .
Quantitative PCR of fadD23 cDNA was compared among serial clinical isolates. We observed significant reductions in the levels of fadD23 cDNA in the later-collected isolates, suggesting suppressed expression of fadD23, potentially leading to reduced synthesis of complex lipids (Fig. 6) .
DISCUSSION
In the work-up of cultures for identification and susceptibility testing of MABSC, it is important to note any evidence of mixed populations on the culture plate reflecting a heterogeneous population of in the patient sample. A recent study (35) highlighted this issue by documenting the coisolation of MABSC strains with smooth and rough morphotypes harboring different clarithromycin resistance mechanisms and susceptibility profiles. This work describes additional changes occurring in MABSC over time that may take place prior to noticeable colony morphology changes.
Our results indicate that the rough morphology of M. abscessus is associated with the loss of GPL and emerges during chronic, persistent human infection. It should be noted that one of the patients in the study (patient 3) had a disseminated infection due to interferon gamma autoantibodies, the pathophysiology of which is quite different from that of idiopathic bronchiectasis (33) . Nevertheless the observed changes in the pathogen genetics and colony morphology in the serial isolates from patient 3 were congruent with those for the other patient isolates. Therefore, these changes may not be specific to patients with idiopathic bronchiectasis but may reflect prolonged human infection, treatment, or both.
We identified an underlying genetic change in 77% of rough isolates in this study: spontaneous indels, large deletions, and a nonsense mutation in mps1-mps2. These two adjacent genes, likely in one operon, encode nonribosomal peptide synthetases that play indispensable roles in the synthesis of tripeptide-amino alcohol, the core GPL molecule to which fatty acids and complex sugars are attached (9) . Inactivating mutations in these genes likely stop GPL synthesis at the very beginning of the pathway. If abandoning GPL production confers selective advantages to the organism in the human environment, as is suggested by our results, it is plausible that isolates with mutations in mps1-map2 would be selected over others because disrupting mps1-mps2 may be the most efficient way for the organism to stop GPL synthesis.
Detrimental mutations in mmpS4-mmpL4a, found in 13% of the rough isolates, are less obvious than mps1-mps2 mutations as causes of loss of GPL, due to the paucity of data on these genes. Deshayes et al. (24) deleted mmpS4 in M. smegmatis, thereby causing a switch from smooth to rough morphology, although the mutant was still able to produce a small amount of a "GPL-like molecule." MALDI-TOF MS of the lipid extract from this mutant had a major peak 14 Da higher than that of the wild-type GPL. The authors suggested an additional fatty acid O-methylation, the removal of which is dependent on an intact mmpS4 gene. Interestingly, the same degree of increase in the major peak in MALDI-TOF MS was observed in our spontaneous mmpS4 mutants compared to smooth clinical isolates. The most plausible explanation is that this molecule is a GPL precursor but probably not able to manifest the phenotypic features of GPL. The morphology of the mmpS4 mutants was unequivocally rough, and their TLC analysis did not show GPL bands (Fig. 4) . The overlapping findings between our results and those of Deshayes et al. (24) imply that mmpS4 may have a significant role in GPL synthesis. mmpL4a, on the other hand, has not been studied experimentally. The detrimental mutations found in this gene are uncertain causes of the loss of GPL. We suspect that it has a role in GPL synthesis/transport, based on its adjacency to mmpL4b and its apparent indispensability to GPL synthesis (25) .
MALDI-TOF MS applications in clinical microbiology have been primarily focused on microbial identification. Our work provides an example of additional applications of the same platform used in the clinical laboratory for the detection of mycobacterial lipid molecules, which unveil adaptive and virulence changes.
We identified different GPL locus mutations among the rough isolates from individual patients (patients 1, 4, 5, 7, and 9) ( Table  2) , as well as recovered smooth isolates [1-7(S) and 7-6(S)] late in the disease course after several years of recovering only rough isolates. Infection by new strains is less likely, as serial patient isolates were closely related genetically based on our MLST analysis (Fig. 1) . More plausible is the coexistence of multiple subpopulations, all diversified from an initial M. abscessus strain. Some bacterial subpopulations likely predominate during the course of the infection, hence being more likely to be recovered in culture. Coexistence of diverse lineages has been observed during chronic Burkholderia dolosa infection in CF patients (34) . Conventional culture and colony selection methods for sputum and bronchoalveolar lavage samples typically yield a predominant strain(s) and likely miss subpopulations occurring simultaneously. Therefore, conventional culture methods could lead to biased results due to lack of information on the collective bacterial population at the time of sputum collection.
There is remarkable variation in rough morphology among the isolates from a single patient, independent of the underlying mutation that led to loss of GPL. Isolates with rough morphology became less defined and structured later in disease in some cases (patients 4, 5 and 6). On the other hand, we found no deleterious mutations in two rough isolates lacking GPL. We postulate that although loss of GPL is sufficient for rough morphology, there may be other genetic changes that cause or affect rough colony morphology.
The accumulation of TAG and the reduced expression of fadD23, a gene in the GPL locus involved in activation of fatty acids for synthesis of complex lipids like GPL, were observed in later-collected isolates. On the basis of these findings as well as the similar adaptive changes seen in chronically infective M. tuberculosis (26) (27) (28) (29) , we can hypothesize that M. abscessus may gain selective advantages, through yet-unknown mechanisms, from storing fatty acids as TAG instead of using them for synthesis of complex lipids in the human lung environment. If so, loss of GPL, the most abundant complex glycolipid, could be one of multiple changes that occur under this adaptive process. Accordingly, the absence of GPL alone may not account for the reported pathogenicity associated with rough clinical strains of M. abscessus.
